Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
DOI:
https://doi.org/10.1590/S1678-9946202264043Abstract
not applicable
Downloads
Download data is not yet available.
Downloads
Published
2022-06-20
Issue
Section
Letter to the Editor
License
Copyright (c) 2022 Almir Ribeiro da Silva Jr, Lucy Santos Villas-Boas, Anderson Vicente de Paula, Tania Regina Tozetto-Mendoza, Layla Honorato, Steven S. Witkin, Maria Cassia Mendes-Correa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Silva Jr, A. R. da ., Villas-Boas, L. S. ., Paula, A. V. de ., Tozetto-Mendoza, T. R. ., Honorato, L. ., Witkin, S. S. ., & Mendes-Correa, M. C. . (2022). Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster. Revista Do Instituto De Medicina Tropical De São Paulo, 64, e43. https://doi.org/10.1590/S1678-9946202264043